Ebenezer David

1.1k total citations
20 papers, 514 citations indexed

About

Ebenezer David is a scholar working on Molecular Biology, Hematology and Epidemiology. According to data from OpenAlex, Ebenezer David has authored 20 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Hematology and 3 papers in Epidemiology. Recurrent topics in Ebenezer David's work include Multiple Myeloma Research and Treatments (5 papers), RNA Interference and Gene Delivery (5 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). Ebenezer David is often cited by papers focused on Multiple Myeloma Research and Treatments (5 papers), RNA Interference and Gene Delivery (5 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). Ebenezer David collaborates with scholars based in United States, Switzerland and Poland. Ebenezer David's co-authors include Beatriz M. A. Fontoura, R. B. Carroll, Елена А. Сорокина, Sagar Lonial, Patrick Hearing, Edmund K. Waller, Renu Kakar, Bernard Mach, Bénédicte Durand and P. Emery and has published in prestigious journals such as Journal of Biological Chemistry, Blood and The Journal of Immunology.

In The Last Decade

Ebenezer David

20 papers receiving 507 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ebenezer David United States 12 342 167 108 98 72 20 514
Marcel Roza Netherlands 8 253 0.7× 156 0.9× 116 1.1× 142 1.4× 69 1.0× 10 541
Teruhisa Otsuka Japan 10 153 0.4× 100 0.6× 133 1.2× 65 0.7× 56 0.8× 30 407
Adam Cisterne Australia 9 225 0.7× 137 0.8× 151 1.4× 233 2.4× 54 0.8× 14 571
Aleksandra A. Watson United Kingdom 10 267 0.8× 119 0.7× 138 1.3× 127 1.3× 16 0.2× 14 516
Cécile Tétaud France 13 214 0.6× 191 1.1× 315 2.9× 96 1.0× 52 0.7× 15 662
Vernon M. Coffield United States 10 794 2.3× 105 0.6× 249 2.3× 223 2.3× 61 0.8× 13 1.0k
Armelle Goubard France 13 262 0.8× 221 1.3× 205 1.9× 65 0.7× 36 0.5× 25 586
Teresa Laı́n de Lera Spain 8 239 0.7× 103 0.6× 177 1.6× 37 0.4× 59 0.8× 9 506
G.C. Spagnoli Switzerland 14 305 0.9× 176 1.1× 478 4.4× 59 0.6× 40 0.6× 23 679
Caryll Waugh Australia 11 299 0.9× 171 1.0× 274 2.5× 54 0.6× 28 0.4× 12 628

Countries citing papers authored by Ebenezer David

Since Specialization
Citations

This map shows the geographic impact of Ebenezer David's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ebenezer David with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ebenezer David more than expected).

Fields of papers citing papers by Ebenezer David

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ebenezer David. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ebenezer David. The network helps show where Ebenezer David may publish in the future.

Co-authorship network of co-authors of Ebenezer David

This figure shows the co-authorship network connecting the top 25 collaborators of Ebenezer David. A scholar is included among the top collaborators of Ebenezer David based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ebenezer David. Ebenezer David is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hossain, Mohammad Salim, David L. Jaye, Brian P. Pollack, et al.. (2011). Flagellin, a TLR5 Agonist, Reduces Graft-versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplantation Recipients While Enhancing Antiviral Immunity. The Journal of Immunology. 187(10). 5130–5140. 43 indexed citations
2.
David, Ebenezer, Jonathan L. Kaufman, Christopher R. Flowers, et al.. (2010). Tipifarnib sensitizes cells to proteasome inhibition by blocking degradation of bortezomib-induced aggresomes. Blood. 116(24). 5285–5288. 19 indexed citations
3.
David, Ebenezer, Sagar Lonial, Benjamin G. Barwick, et al.. (2009). B358 SF1126, A Novel PI3K Inhibitor Results in Downstream Inhibition of the PI3K Axis and Displays Sequen. Clinical Lymphoma & Myeloma. 9. S127–S127. 1 indexed citations
4.
Lonial, Sagar, Claire Torre, Ebenezer David, et al.. (2008). Regulation of alloimmune responses by dendritic cell subsets. Experimental Hematology. 36(10). 1309–1317. 11 indexed citations
5.
David, Ebenezer, Rajni Sinha, Jing Chen, et al.. (2008). Perifosine Synergistically Enhances TRAIL-Induced Myeloma Cell Apoptosis via Up-Regulation of Death Receptors. Clinical Cancer Research. 14(16). 5090–5098. 31 indexed citations
6.
David, Ebenezer, Xiaodong Peng, Benjamin G. Barwick, et al.. (2008). SF1126, a Novel PI3K Inhibitor Results in Downstream Inhibition of the PI3K Axis and Displays Sequence Specific Synergy When Combined with Bortezomib in Multiple Myeloma Cells. Blood. 112(11). 5167–5167. 4 indexed citations
7.
Torre, Claire, Ebenezer David, Leif Bergsagel, et al.. (2007). A Novel Pan-PI3K/Akt Inhibitor, SF1126, Inhibits In Vitro Growth of Multiple Myeloma Cells.. Blood. 110(11). 4806–4806. 3 indexed citations
8.
David, Ebenezer, Katherine Schafer-Hales, Adam I. Marcus, Jonathan L. Kaufman, & Sagar Lonial. (2007). Combination of Bortezomib with Tipifarnib (R115777) Induces Synergistic Myeloma Cell Apoptosis Via Down-Regulation of HDAC6 and Inhibition of Aggresome Formation.. Blood. 110(11). 1520–1520. 5 indexed citations
9.
David, Ebenezer, Rajni Sinha, Jonathan L. Kaufman, & Sagar Lonial. (2006). Perifosine Induces DR4/DR5 Expression Leading to Apoptosis That Can Be Enhanced with Exogenous TRAIL, and Blocked with Strategies Directed at DR4/DR5 Inhibition.. Blood. 108(11). 3446–3446. 1 indexed citations
10.
11.
12.
13.
14.
15.
16.
David, Ebenezer, Alonzo D. García, & Patrick Hearing. (1995). Interaction of EF-C/RFX-1 with the Inverted Repeat of Viral Enhancer Regions Is Required for Transactivation. Journal of Biological Chemistry. 270(14). 8353–8360. 22 indexed citations
17.
Siegrist, Claire‐Anne, Bénédicte Durand, P. Emery, et al.. (1993). RFX1 is Identical to Enhancer Factor C and Functions as a Transactivator of the Hepatitis B Virus Enhancer. Molecular and Cellular Biology. 13(10). 6375–6384. 71 indexed citations
18.
Durand, Bénédicte, P. Emery, Ebenezer David, et al.. (1993). RFX1 is identical to enhancer factor C and functions as a transactivator of the hepatitis B virus enhancer.. Molecular and Cellular Biology. 13(10). 6375–6384. 28 indexed citations
19.
Fontoura, Beatriz M. A., Елена А. Сорокина, Ebenezer David, & R. B. Carroll. (1992). p53 Is Covalently Linked to 5.8S rRNA. Molecular and Cellular Biology. 12(11). 5145–5151. 38 indexed citations
20.
Fontoura, Beatriz M. A., Елена А. Сорокина, Ebenezer David, & R. B. Carroll. (1992). p53 is covalently linked to 5.8S rRNA.. Molecular and Cellular Biology. 12(11). 5145–5151. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marcel Roza Breakdown of academic impact, for papers by Teruhisa Otsuka Breakdown of academic impact, for papers by Adam Cisterne Breakdown of academic impact, for papers by Aleksandra A. Watson Breakdown of academic impact, for papers by Cécile Tétaud Breakdown of academic impact, for papers by Vernon M. Coffield Breakdown of academic impact, for papers by Armelle Goubard Breakdown of academic impact, for papers by Teresa Laı́n de Lera Breakdown of academic impact, for papers by G.C. Spagnoli Breakdown of academic impact, for papers by Caryll Waugh
Rankless by CCL
2026